WD6-30962-85884
2 vaccinations
1 coded response
17 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 335 / FL
- Registered
- 2021-06-29
- Relationship
- Self
- Race
- White
- Ethnicity
- N/A
Timeline
-
2021-06-28
Dose 1 — Moderna
-
2021-06-29
Registered in v-safe
- 2021-06-29
- 2021-06-30
- 2021-07-01
-
2021-07-26
Dose 2 — Moderna
-
2021-07-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
- 2021-07-28
- 2021-07-29
- 2021-07-30
- 2021-08-01
- 2021-08-02
- 2021-08-09
- 2021-08-16
- 2021-08-23
- 2021-08-30
- 2021-09-06
- 2021-10-25
- 2022-01-24
-
2022-07-26
Survey response — 12 months, dose 2MedDRA: Influenza, Nasopharyngitis — Feeling: Good · Be unable to do your normal daily activitiesFree text: Cold/flu symptomsMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-28 | Moderna | No |
| 2 | 2021-07-26 | Moderna | No |
Free text
Release 12 — 12 months, dose 2
Symptoms: Cold/flu symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Influenza | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release